Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 1616-1619, April 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Felix, K.
Right arrow Articles by Janz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Felix, K.
Right arrow Articles by Janz, S.

Association of Elevated Mutagenesis in the Spleen with Genetic Susceptibility to Induced Plasmacytoma Development in Mice1

Klaus Felix2, Kevin Kelliher, Georg-Wilhelm Bornkamm and Siegfried Janz

Laboratory of Genetics, DBS, National Cancer Institute, NIH, Bethesda, Maryland 20892-4255 [K. F., K. K., S. J.], and Institut für Klinische Molekularbiologie and Tumorgenetik, GSF, Munich, Germany [K. F., G-W. B.]

Using the phage {lambda}LIZ-based transgenic in vivo mutagenesis assay, mean mutant rates were determined in the spleen of mice exposed to sustained oxidative stress and were found to be increased approximately 3-fold in plasmacytoma-susceptible BALB/c and C.D2-Idh1-Pep3 mice, but not in plasmacytoma-resistant DBA/2N mice. This finding suggests a correlation between the genetic susceptibility to inflammation-induced peritoneal plasmacytomagenesis and the phenotype of increased mutagenesis in lymphoid tissues, raising the possibility that plasmacytoma resistance genes may inhibit tumor development by minimizing oxidative mutagenesis in B cells.

1 Supported in part by a grant from the Mildred-Scheel-Stiftung for cancer research (to G-W. B.).

2 To whom requests for reprints should be addressed, at Laboratory of Genetics, National Cancer Institute, NIH, Building 37, Room 2B03, Bethesda, MD 20892-4255. Phone: (301) 496-2101; Fax: (301) 402-1031; E-mail: felixk@dc37a.nci.nih.gov.

Received 1/22/98. Accepted 3/ 3/98.




This article has been cited by other articles:


Home page
Cancer Res.Home page
K. Felix, K. A. Kelliher, G.-W. Bornkamm, and S. Janz
Elevated Mutant Frequencies in Lymphoid Tissues Persist throughout Plasmacytoma Development in BALB/c.{{lambda}}LIZ Mice
Cancer Res., August 1, 1999; 59(15): 3621 - 3626.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.